Evidence map›Paper›PMID 37293586›Full record

ArticleFrontiers in oncology2023

Efficacy of radiomics model based on the concept of gross tumor volume and clinical target volume in predicting occult lymph node metastasis in non-small cell lung cancer.

Chao Zeng, Wei Zhang, Meiyue Liu, Jianping Liu, Qiangxin Zheng, Jianing Li, Zhiwu Wang, Guogui Sun

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chao ZengHebei Key Laboratory of Medical-industrial Integration Precision Medicine, Clinical Medicine College, Affiliated Hospital, North China University of Science and Technology, Tangshan, Hebei, China.
Wei ZhangDepartment of Radiotherapy, Yantai Yuhuangding Hospital, The Affiliated Hospital of Qingdao University, Yantai, Shandong, China.
Meiyue LiuHebei Key Laboratory of Medical-industrial Integration Precision Medicine, Clinical Medicine College, Affiliated Hospital, North China University of Science and Technology, Tangshan, Hebei, China.
Jianping LiuDepartment of Chemoradiation, Tangshan People's Hospital, Tangshan, Hebei, China.
Qiangxin ZhengHebei Key Laboratory of Medical-industrial Integration Precision Medicine, Clinical Medicine College, Affiliated Hospital, North China University of Science and Technology, Tangshan, Hebei, China.
Jianing LiHebei Key Laboratory of Medical-industrial Integration Precision Medicine, Clinical Medicine College, Affiliated Hospital, North China University of Science and Technology, Tangshan, Hebei, China.
Zhiwu WangDepartment of Chemoradiation, Tangshan People's Hospital, Tangshan, Hebei, China.
Guogui SunHebei Key Laboratory of Medical-industrial Integration Precision Medicine, Clinical Medicine College, Affiliated Hospital, North China University of Science and Technology, Tangshan, Hebei, China.
North China University of Science and Technology · CNTangshan People's Hospital · CNYuhuangding Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to establish a predictive model for occult lymph node metastasis (LNM) in patients with clinical stage I-A non-small cell lung cancer (NSCLC) based on contrast-enhanced CT. Methods: A total of 598 patients with stage I-IIA NSCLC from different hospitals were randomized into the training and validation group. The "Radiomics" tool kit of AccuContour software was employed to extract the radiomics features of GTV and CTV from chest-enhanced CT arterial phase pictures. Then, the least absolute shrinkage and selection operator (LASSO) regression analysis was applied to reduce the number of variables and develop GTV, CTV, and GTV+CTV models for predicting occult lymph node metastasis (LNM). Results: Eight optimal radiomics features related to occult LNM were finally identified. The receiver operating characteristic (ROC) curves of the three models showed good predictive effects. The area under the curve (AUC) value of GTV, CTV, and GTV+CTV model in the training group was 0.845, 0.843, and 0.869, respectively. Similarly, the corresponding AUC values in the validation group were 0.821, 0.812, and 0.906. The combined GTV+CTV model exhibited a better predictive performance in the training and validation group by the Delong test ( Conclusion: The radiomics prediction models based on GTV and CTV can predict occult LNM in patients with clinical stage I-IIA NSCLC preoperatively, and the combined GTV+CTV model is the optimal strategy for clinical application.

Indexed as

chest-enhanced CTnon-small cell lung canceroccult lymph node metastasisprediction modelradiomics

Identifiers

PMID37293586
PMCPMC10246750
OpenAlexW4377942465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.